Vishal Gupta, PhD joined Mallinckrodt Specialty Generics in May 2020 as Chief Scientific Officer and Senior Vice President. In this capacity, he is responsible for all aspects of Generics and 505(b)(2) R&D including CMC, Clinical Pharmacology, Regulatory Affairs, Project Management, Portfolio Management, and Strategy.
Mr. Gupta has extensive industry and private equity experience in a career spanning over 20 years. He served as Senior Vice President, US R&D at Alvogen; Chief Scientific Officer, SVP and Global Head of Generics R&D at Impax Labs; and Chief Scientific Officer, SVP at CorePharma. He also served in positions of increasing responsibility at Mallinckrodt, Pfizer, and Ranbaxy early in his career.
Mr. Gupta holds a PhD in Pharmaceutics from The University of Georgia, Athens, GA; an MBA in Strategy and Finance from Washington University, St. Louis, MO; an MS in Pharmaceutics from IIT, Banaras Hindu University, India, and a BS in Pharmacy from Amravati University, India. Vishal is a certified Six Sigma Black Belt and a former Officer of the American Association of Pharmaceutical Scientists. He served as Adjunct Assistant Professor at Midwestern College of Pharmacy, Chicago, IL and St. Louis College of Pharmacy, St. Louis, MO.